NovaBridge Biosciences American Depositary Shares
NBP
48 hedge funds and large institutions have $72.1M invested in NovaBridge Biosciences American Depositary Shares in 2026 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 15 reducing their positions, and 18 closing their positions.
9,700% more call options, than puts
Call options by funds: $98K | Put options by funds: $1K
7% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 15
3.38% less ownership
Funds ownership: 28.8% → 25.43% (-3.4%)
16% less funds holding
Funds holding: 57 → 48 (-9)
45% less capital invested
Capital invested by funds: $132M → $72.1M (-$60.1M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
50% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIHC Capital Management
Central,
|
+$6.19M |
| 2 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
+$1.06M |
| 3 |
Renaissance Technologies
New York
|
+$912K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$558K |
| 5 |
HF
HRT Financial
New York
|
+$360K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$8.05M |
| 2 |
ACM
Ariose Capital Management
Central, Hong Kong,
Hong Kong
|
-$5.43M |
| 3 |
Millennium Management
New York
|
-$3.37M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.04M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$1.17M |
NBP Hedge Fund Activity: Q1 2026 in Review
48 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q1 2026, worth a combined $72.1M — down 45% from $132M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of NBP and 9 opened new positions — a net loss of 9 holders — while 15 trimmed existing stakes and 14 added.
The largest buyer was AIHC Capital Management, adding an estimated $6.19M. The largest seller was Janus Henderson Group, cutting an estimated $8.05M.
- 48 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q1 2026, down from 57 in Q4 2025.
- Funds reported $72.1M of NovaBridge Biosciences American Depositary Shares stock for Q1 2026, down 45% quarter-over-quarter.
- 9 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q1 2026 and 18 closed out, a net change of -9 holders.
- The largest NovaBridge Biosciences American Depositary Shares buyer in Q1 2026 was AIHC Capital Management, an estimated $6.19M added.
- The largest NovaBridge Biosciences American Depositary Shares seller in Q1 2026 was Janus Henderson Group, an estimated $8.05M sold.
Based on aggregated 13F filings for Q1 2026.